{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:34:37Z","timestamp":1792784077770,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Department of Health, Kaohsiung City Government"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jfma.2020.10.008","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T12:40:03Z","timestamp":1603456803000},"page":"1350-1360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["An observational study on prevalence of latent tuberculosis infection and outcome of 3HP treatment in patients under hemodialysis in Taiwan"],"prefix":"10.1016","volume":"120","author":[{"given":"Chien-Hsing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-An","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-An","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jien-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Te","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo-Hsin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2020.10.008_bib1","series-title":"Global tuberculosis report 2019","author":"Baddeley","year":"2019"},{"key":"10.1016\/j.jfma.2020.10.008_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2016.11.006","article-title":"Preventive therapy for latent tuberculosis infection-the promise and the challenges","volume":"56","author":"Fox","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.jfma.2020.10.008_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2215\/CJN.09231209","article-title":"Diagnosis of tuberculosis in dialysis patients: current strategy","volume":"5","author":"Segall","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"22","key":"10.1016\/j.jfma.2020.10.008_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003813","article-title":"Risk of tuberculosis among patients on dialysis: the predictive value of serial interferon-gamma release assay","volume":"95","author":"Shu","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.jfma.2020.10.008_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jiph.2013.02.002","article-title":"Comparison of the tuberculin skin test and Quanti-FERON-TB Gold In-Tube (QFT-G) test for the diagnosis of latent tuberculosis infection in dialysis patients","volume":"6","author":"AlJahdali","year":"2013","journal-title":"J Infect Public Health"},{"issue":"2","key":"10.1016\/j.jfma.2020.10.008_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s15010-008-8082-3","article-title":"High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test","volume":"37","author":"Lee","year":"2009","journal-title":"Infection"},{"issue":"8","key":"10.1016\/j.jfma.2020.10.008_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042592","article-title":"Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis","volume":"7","author":"Shu","year":"2012","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.jfma.2020.10.008_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124104","article-title":"Comparison of the prevalence of latent tuberculosis infection among non-dialysis patients with severe chronic kidney disease, patients receiving dialysis, and the dialysis-unit staff: a cross-sectional study","volume":"10","author":"Shu","year":"2015","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.jfma.2020.10.008_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073069","article-title":"Strategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated population","volume":"8","author":"Yang","year":"2013","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.jfma.2020.10.008_bib10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2215\/CJN.01790210","article-title":"High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test","volume":"5","author":"Lee","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2020.10.008_bib11","series-title":"Taiwan guidelines for TB diagnosis & treatment [Internet]. Sixth","author":"Chiang","year":"2017"},{"issue":"23","key":"10.1016\/j.jfma.2020.10.008_bib12","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jfma.2020.10.008_bib13","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.5588\/ijtld.18.0168","article-title":"Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review","volume":"22","author":"Hamada","year":"2018","journal-title":"Int J Tubercul Lung Dis"},{"issue":"4","key":"10.1016\/j.jfma.2020.10.008_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/civ323","article-title":"Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT tuberculosis study","volume":"61","author":"Sterling","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jfma.2020.10.008_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jmii.2018.05.003","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection in hemodialysis patients: high rates of adverse events","volume":"52","author":"Lin","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2020.10.008_bib16","series-title":"Common terminology criteria for adverse events (CTCAE) version 5.0","year":"2017"},{"issue":"12","key":"10.1016\/j.jfma.2020.10.008_bib17","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.5588\/ijtld.15.0081","article-title":"Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis","volume":"19","author":"Al-Efraij","year":"2015","journal-title":"Int J Tubercul Lung Dis"},{"issue":"1","key":"10.1016\/j.jfma.2020.10.008_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S0950268813000551","article-title":"Increased risk of tuberculosis in patients with end-stage renal disease: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease","volume":"142","author":"Hu","year":"2014","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.jfma.2020.10.008_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s15010-012-0291-0","article-title":"Comparison of the tuberculin skin test and interferon-\u03b3 release assay for the diagnosis of latent tuberculosis infection before kidney transplantation","volume":"41","author":"Kim","year":"2013","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.jfma.2020.10.008_bib20","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/ndt\/gfr516","article-title":"Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?","volume":"27","author":"Soysal","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2020.10.008_bib21","doi-asserted-by":"crossref","first-page":"19972","DOI":"10.1038\/srep19972","article-title":"Effects of acute critical illnesses on the performance of interferon-gamma release assay","volume":"6","author":"Huang","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jfma.2020.10.008_bib22","doi-asserted-by":"crossref","first-page":"142S","DOI":"10.1378\/chest.128.4_MeetingAbstracts.142S","article-title":"Relationship between tuberculin hypersensitivity and serum albumin levels in patients with active tuberculosis","volume":"128","author":"Michaelides","year":"2005","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jfma.2020.10.008_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/1687-8426.158086","article-title":"Comparative study between tuberculin skin test and serum albumin level in patients with active pulmonary tuberculosis","volume":"9","author":"Mohammad","year":"2015","journal-title":"Egypt J Bronchol"},{"issue":"3","key":"10.1016\/j.jfma.2020.10.008_bib24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MPG.0000000000000205","article-title":"Disease activity is an important factor for indeterminate interferon-\u03b3 release assay results in children with inflammatory bowel disease","volume":"58","author":"Hradsky","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.jfma.2020.10.008_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102299","article-title":"Nutritional adequacy and latent tuberculosis infection in end-stage renal disease patients","volume":"11","author":"Baek","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jfma.2020.10.008_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0042-6822(75)90028-8","article-title":"The human interferon-albumin interaction: the influence of albumin conformation","volume":"65","author":"Huang","year":"1975","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.jfma.2020.10.008_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/ijmy.ijmy_211_19","article-title":"Risk factors for hypercalcemia in patients with tuberculosis","volume":"9","author":"John","year":"2020","journal-title":"Int J mycobacteriology"},{"issue":"2","key":"10.1016\/j.jfma.2020.10.008_bib28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4103\/2249-4863.192327","article-title":"Severe hypercalcemia in a patient with pulmonary tuberculosis","volume":"5","author":"Rajendra","year":"2016","journal-title":"J Fam Med Prim Care"},{"issue":"3","key":"10.1016\/j.jfma.2020.10.008_bib29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s11914-017-0368-x","article-title":"Calcium balance in chronic kidney disease","volume":"15","author":"Hill Gallant","year":"2017","journal-title":"Curr Osteoporos Rep"},{"issue":"6","key":"10.1016\/j.jfma.2020.10.008_bib30","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/TP.0000000000001329","article-title":"Twelve-week rifapentine plus isoniazid versus 9-month isoniazid for the treatment of latent tuberculosis in renal transplant candidates","volume":"101","author":"Simkins","year":"2017","journal-title":"Transplantation"},{"issue":"34","key":"10.1016\/j.jfma.2020.10.008_bib31","doi-asserted-by":"crossref","first-page":"e4126","DOI":"10.1097\/MD.0000000000004126","article-title":"Impacts of 12-dose regimen for latent tuberculosis infection: treatment completion rate and cost-effectiveness in Taiwan","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.jfma.2020.10.008_bib32","doi-asserted-by":"crossref","first-page":"ofv220","DOI":"10.1093\/ofid\/ofv220","article-title":"Completion rate and side-effect profile of three-month isoniazid and rifapentine treatment for latent tuberculosis infection in an urban county jail","volume":"3","author":"Juarez-Reyes","year":"2016","journal-title":"Open forum Infect Dis"},{"issue":"10","key":"10.1016\/j.jfma.2020.10.008_bib33","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/QAD.0000000000001098","article-title":"Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons","volume":"30","author":"Sterling","year":"2016","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.jfma.2020.10.008_bib34","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/cid\/cix505","article-title":"High rate of treatment completion in program settings with 12-dose weekly isoniazid and rifapentine for latent Mycobacterium tuberculosis infection","volume":"65","author":"Sandul","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2020.10.008_bib35","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-2838","article-title":"Completion rate and safety of tuberculosis infection treatment with shorter regimens","volume":"141","author":"Cruz","year":"2018","journal-title":"Pediatrics"},{"issue":"1_suppl","key":"10.1016\/j.jfma.2020.10.008_bib36","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1177\/0033354919826557","article-title":"Completion rates, adverse effects, and costs of a 3-month and 9-month treatment regimen for latent tuberculosis infection in California inmates, 2011-2014","volume":"134","author":"Wheeler","year":"2019","journal-title":"Publ Health Rep"},{"issue":"5","key":"10.1016\/j.jfma.2020.10.008_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/1060028019888855","article-title":"Evaluation of 3 Months of once-weekly rifapentine and isoniazid for latent tuberculosis infection","volume":"54","author":"Walker","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jfma.2020.10.008_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.tube.2018.05.013","article-title":"Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: a multicentre randomised controlled trial in Taiwan","volume":"111","author":"Sun","year":"2018","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.jfma.2020.10.008_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2215\/CJN.01280406","article-title":"Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel","volume":"2","author":"Passalent","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.jfma.2020.10.008_bib40","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2215\/CJN.01010208","article-title":"Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients","volume":"3","author":"Winthrop","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.jfma.2020.10.008_bib41","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/ndt\/gfp030","article-title":"The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients","volume":"24","author":"Inoue","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.jfma.2020.10.008_bib42","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/ndt\/gfn748","article-title":"Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients","volume":"24","author":"Triverio","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.jfma.2020.10.008_bib43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1469-0691.2009.02949.x","article-title":"Validity of interferon-\u03b3-release assays for the diagnosis of latent tuberculosis in haemodialysis patients","volume":"16","author":"Chung","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.jfma.2020.10.008_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-3062.2009.00469.x","article-title":"Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients","volume":"12","author":"Seyhan","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2020.10.008_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5578\/tt.2353","article-title":"QuantiFERON-TB Gold test for screening latent tuberculosis infection in hemodialysis patients","volume":"59","author":"Sayarlio\u011flu","year":"2011","journal-title":"Tuberk Toraks"},{"key":"10.1016\/j.jfma.2020.10.008_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2334-12-195","article-title":"Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to","volume":"12","author":"Anibarro","year":"2012","journal-title":"M. tuberculosis. BMC Infect Dis."},{"issue":"3","key":"10.1016\/j.jfma.2020.10.008_bib47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1155\/2012\/287181","article-title":"Interferon-gamma release assays are a better tuberculosis screening test for hemodialysis patients: a study and review of the literature","volume":"23","author":"Grant","year":"2012","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"6","key":"10.1016\/j.jfma.2020.10.008_bib48","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jinf.2013.07.029","article-title":"Dynamic changes in positive interferon-gamma release assay in a dialysis population: an observational cohort study","volume":"67","author":"Shu","year":"2013","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.jfma.2020.10.008_bib49","first-page":"329","article-title":"Interferon-gamma release assay agreement with tuberculin skin test in pretransplant screening for latent tuberculosis in a high-prevalence country","volume":"8","author":"Savaj","year":"2014","journal-title":"Iran J Kidney Dis"},{"issue":"4","key":"10.1016\/j.jfma.2020.10.008_bib50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4103\/0971-5916.159297","article-title":"Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis","volume":"141","author":"Agarwal","year":"2015","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jfma.2020.10.008_bib51","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12879-015-1117-3","article-title":"Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jfma.2020.10.008_bib52","doi-asserted-by":"crossref","first-page":"34577","DOI":"10.1038\/srep34577","article-title":"Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis population","volume":"6","author":"Shu","year":"2016","journal-title":"Sci Rep"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462030468X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462030468X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:44:38Z","timestamp":1760539478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966462030468X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S092966462030468X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2020.10.008","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An observational study on prevalence of latent tuberculosis infection and outcome of 3HP treatment in patients under hemodialysis in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2020.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}